Five Ways Advanced Social Intelligence Guides Pharma Strategy

Mark Langsfield | | June 4, 2013

Within the billions of daily comments from individuals across open social sources lies deep intelligence into markets, brands, patients, caregivers, healthcare providers and competitors. Several leading pharmaceutical companies are already using big data solutions to extract insights from the social realm. Applying these insights across a number of business functions empowers their decision-making with strategic understanding that digs deeper than ever before possible.

Today, social intelligence has advanced well beyond cursory “buzz” via narrow keyword monitoring. The tandem of big data processing and complex concept modeling delivers deep, powerful views into markets, patients, brands and competitors.

Here are five ways pharmaceuticals are currently leveraging advanced social intelligence to drive strategic decisions: